Review article| Volume 259, P153-160, April 2021

Download started.


Biodegradable materials for surgical management of stress urinary incontinence: A narrative review

Published:February 26, 2021DOI:


      Stress urinary incontinence (SUI) was managed with techniques such as colposuspension, autologous fascia sling and urethral bulking agents. The introduction of the mid-urethral polypropylene (PP) sling in the 1990s led to a significant and rapid global change in SUI surgery. The synthetic non-degradable PP sling had superior results to traditional SUI procedures but its use has now declined due to significant complications such as pain and mesh erosion. These complications are attributed to its poor biocompatibility and integration into vaginal tissues. The efficacy of PP was extrapolated from studies on abdominal wall repair and it is now clear that integration of implanted materials in the pelvic floor differs from the abdominal wall. With PP prohibited in some jurisdictions, female patients with SUI have few management options. In the present review we summarise recent advances in SUI surgery and evaluate potential alternatives to PP slings with a particular focus on degradable materials. Allograft and xenograft materials demonstrate good biocompatibility but have yielded suboptimal cure rates. Tissue engineered synthetic degradable materials outperform unmodified synthetic degradable materials in terms of biomechanics and cell support. Synthetic tissue engineered degradable materials show promising results from in vitro studies and future research should focus on animal and human trials in this field.


      PP (polypropylene), SUI (stress urinary incontinence), MUS (mid-urethral sling), POP (pelvic organ prolapse), FDA (food and drug administration), ECM (extracellular matrix), PLA (polylactic acid), ADSC (adipose derived stem cells), PLGA (Poly-DL-lactico-glycolic acid), PLGA/PCL (poly(glycolide-co-lactide acid)-blended-poly(caprolactone), SIS (small intestinal submucosa), LPP (leak-point pressure), MPa (megapascal), eMSC (endometrial mesenchymal stem cells), PA (polyamide)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Abrams P.
        • et al.
        The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.
        Urology. 2003; 61: 37-49
        • Norton P.
        • Brubaker L.
        Urinary incontinence in women.
        Lancet. 2006; 367: 57-67
        • Subak L.L.
        • et al.
        Cost of pelvic organ prolapse surgery in the United States.
        Obstet Gynecol. 2001; 98: 646-651
        • Gibson W.
        • Wagg A.
        Are older women more likely to receive surgical treatment for stress urinary incontinence since the introduction of the mid-urethral sling? An examination of Hospital Episode Statistics data.
        BJOG. 2016; 123: 1386-1392
        • Ford A.A.
        • et al.
        Mid-urethral sling operations for stress urinary incontinence in women.
        Cochrane Database Syst Rev. 2015; (p. Cd006375)
        • Rehman H.
        • et al.
        Traditional suburethral sling operations for urinary incontinence in women.
        Cochrane Database Syst Rev. 2017; 7 (p. Cd001754)
        • Kirchin V.
        • et al.
        Urethral injection therapy for urinary incontinence in women.
        Cochrane Database Syst Rev. 2012; (p. Cd003881)
        • Keltie K.
        • et al.
        Complications following vaginal mesh procedures for stress urinary incontinence: an 8 year study of 92,246 women.
        Sci Rep. 2017; 7 (p. 12015)
        • DOH
        Update on the independent medicines and medical devices safety review: written statement – HCWS841 (UK parliament.
        Department of Health and Social Care, 2018
        • Mathieson R.
        • et al.
        Stress urinary incontinence in the mesh complication era: current Australian trends.
        BJU Int. 2020;
        • Mironska E.
        • Chapple C.
        • MacNeil S.
        Recent advances in pelvic floor repair.
        F1000Res. 2019; 8
        • Chapple C.R.
        • et al.
        Application of tissue engineering to pelvic organ prolapse and stress urinary incontinence.
        Low Urin Tract Symptoms. 2015; 7: 63-70
        • Faulk D.M.
        • et al.
        ECM hydrogel coating mitigates the chronic inflammatory response to polypropylene mesh.
        Biomaterials. 2014; 35: 8585-8595
        • Nolfi A.L.
        • et al.
        Host response to synthetic mesh in women with mesh complications.
        Am J Obstet Gynecol. 2016; 215 (p. 206.e1-8)
        • Manodoro S.
        • et al.
        Graft-related complications and biaxial tensiometry following experimental vaginal implantation of flat mesh of variable dimensions.
        Bjog. 2013; 120: 244-250
        • Badylak S.F.
        • et al.
        Macrophage phenotype as a determinant of biologic scaffold remodeling.
        Tissue Eng Part A. 2008; 14: 1835-1842
        • Mangera A.
        • et al.
        Are biomechanical properties predictive of the success of prostheses used in stress urinary incontinence and pelvic organ prolapse? A systematic review.
        Neurourol Urodyn. 2012; 31: 13-21
        • Lei L.
        • Song Y.
        • Chen R.
        Biomechanical properties of prolapsed vaginal tissue in pre- and postmenopausal women.
        Int Urogynecol J Pelvic Floor Dysfunct. 2007; 18: 603-607
        • Heneghan C.J.
        • et al.
        Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process.
        BMJ Open. 2017; 7 (p. e017125)
        • Chapple C.R.
        • et al.
        Consensus statement of the European Urology Association and the European Urogynaecological Association on the use of implanted materials for treating pelvic organ prolapse and stress urinary incontinence.
        Eur Urol. 2017; 72: 424-431
        • FDA
        Reclassification of surgical mesh for transvaginal pelvic organ prolapse repair office of the federal register.
        Obstetrical and Gynecological Devices, 2016
        • Mangera A.
        • et al.
        Comparison of candidate scaffolds for tissue engineering for stress urinary incontinence and pelvic organ prolapse repair.
        BJU Int. 2013; 112: 674-685
        • Roman S.
        • et al.
        Developing a tissue engineered repair material for treatment of stress urinary incontinence and pelvic organ prolapse-which cell source?.
        Neurourol Urodyn. 2014; 33: 531-537
        • Hillary C.J.
        • et al.
        Developing repair materials for stress urinary incontinence to withstand dynamic distension.
        PLoS One. 2016; 11 (p. e0149971)
        • Hung M.J.
        • et al.
        Fascia tissue engineering with human adipose-derived stem cells in a murine model: implications for pelvic floor reconstruction.
        J Formos Med Assoc. 2014; 113: 704-715
        • Labet M.
        • Thielemans W.
        Synthesis of polycaprolactone: a review.
        Chem Soc Rev. 2009; 38: 3484-3504
        • Chang S.H.
        • et al.
        Fast degradable polycaprolactone for drug delivery.
        Biomacromolecules. 2018; 19: 2302-2307
        • Ho C.C.
        • et al.
        The effects of biodentine/polycaprolactone three-dimensional-scaffold with odontogenesis properties on human dental pulp cells.
        Int Endod J. 2018; 51: e291-e300
        • Giri Dev V.R.
        • Hemamalini T.
        Porous electrospun starch rich polycaprolactone blend nanofibers for severe hemorrhage.
        Int J Biol Macromol. 2018; 118: 1276-1283
        • Munir N.
        • Callanan A.
        Novel phase separated polycaprolactone/collagen scaffolds for cartilage tissue engineering.
        Biomed Mater. 2018; 13 (p. 051001)
        • Gomez-Lizarraga K.K.
        • et al.
        Polycaprolactone- and polycaprolactone/ceramic-based 3D-bioplotted porous scaffolds for bone regeneration: a comparative study.
        Mater Sci Eng C Mater Biol Appl. 2017; 79: 326-335
        • Weisgerber D.W.
        • et al.
        A mineralized collagen-polycaprolactone composite promotes healing of a porcine mandibular defect.
        Tissue Eng Part A. 2018; 24: 943-954
        • Hympanova L.
        • et al.
        Physiologic musculofascial compliance following reinforcement with electrospun polycaprolactone-ureidopyrimidinone mesh in a rat model.
        J Mech Behav Biomed Mater. 2017; 74: 349-357
        • Mollet B.B.
        • et al.
        A modular approach to easily processable supramolecular bilayered scaffolds with tailorable properties.
        J Mater Chem B. 2014; 2: 2483-2493
        • Paul K.
        • et al.
        3D bioprinted endometrial stem cells on melt electrospun poly ε-caprolactone mesh for pelvic floor application promote anti-inflammatory responses in mice.
        Acta Biomater. 2019; 97: 162-176
        • Vashaghian M.
        • et al.
        Electrospun matrices for pelvic floor repair: effect of Fiber diameter on mechanical properties and cell behavior.
        Tissue Eng Part A. 2016; 22: 1305-1316
        • Li Q.
        • et al.
        Tissue-engineered mesh for pelvic floor reconstruction fabricated from silk fibroin scaffold with adipose-derived mesenchymal stem cells.
        Cell Tissue Res. 2013; 354: 471-480
        • Zou X.H.
        • et al.
        Mesenchymal stem cell seeded knitted silk sling for the treatment of stress urinary incontinence.
        Biomaterials. 2010; 31: 4872-4879
        • Ulrich D.
        • et al.
        Human endometrial mesenchymal stem cells modulate the tissue response and mechanical behavior of polyamide mesh implants for pelvic organ prolapse repair.
        Tissue Eng Part A. 2014; 20: 785-798
        • Cannon T.W.
        • et al.
        A tissue-engineered suburethral sling in an animal model of stress urinary incontinence.
        BJU Int. 2005; 96: 664-669
        • Siracusano S.
        • et al.
        Porcine small intestinal submucosa implant in pubovaginal sling procedure on 48 consecutive patients: long-term results.
        Eur J Obstet Gynecol Reprod Biol. 2011; 158: 350-353
        • Rutner A.B.
        • Levine S.R.
        • Schmaelzle J.F.
        Processed porcine small intestine submucosa as a graft material for pubovaginal slings: durability and results.
        Urology. 2003; 62: 805-809
        • Wiedemann A.
        • Otto M.
        Small intestinal submucosa for pubourethral sling suspension for the treatment of stress incontinence: first histopathological results in humans.
        J Urol. 2004; 172: 215-218
        • Misseri R.
        • et al.
        Small intestinal submucosa bladder neck slings for incontinence associated with neuropathic bladder.
        J Urol. 2005; 174 (discussion 1682): 1680-1682
        • Jones J.S.
        • et al.
        Porcine small intestinal submucosa as a percutaneous mid-urethral sling: 2-year results.
        BJU Int. 2005; 96: 103-106
        • Serati M.
        • et al.
        Tension-free vaginal tape-obturator for treatment of pure urodynamic stress urinary incontinence: efficacy and adverse effects at 10-year follow-up.
        Eur Urol. 2017; 71: 674-679
        • Abdel-Fattah M.
        • Barrington J.W.
        • Arunkalaivanan A.S.
        Pelvicol pubovaginal sling versus tension-free vaginal tape for treatment of urodynamic stress incontinence: a prospective randomized three-year follow-up study.
        Eur Urol. 2004; 46: 629-635
        • Arunkalaivanan A.S.
        • Barrington J.W.
        Randomized trial of porcine dermal sling (Pelvicol implant) vs. tension-free vaginal tape (TVT) in the surgical treatment of stress incontinence: a questionnaire-based study.
        Int Urogynecol J Pelvic Floor Dysfunct. 2003; 14 (discussion 21-22): 17-23
        • Barrington J.W.
        • et al.
        The use of porcine dermal implant in a minimally invasive pubovaginal sling procedure for genuine stress incontinence.
        BJU Int. 2002; 90: 224-227
        • O’Reilly K.J.
        • Govier F.E.
        Intermediate term failure of pubovaginal slings using cadaveric fascia lata: a case series.
        J Urol. 2002; 167: 1356-1358
        • Dora C.D.
        • et al.
        Time dependent variations in biomechanical properties of cadaveric fascia, porcine dermis, porcine small intestine submucosa, polypropylene mesh and autologous fascia in the rabbit model: implications for sling surgery.
        J Urol. 2004; 171: 1970-1973
        • Krambeck A.E.
        • et al.
        Time-dependent variations in inflammation and scar formation of six different pubovaginal sling materials in the rabbit model.
        Urology. 2006; 67: 1105-1110
        • Yildirim A.
        • et al.
        Tissue reactions of 5 sling materials and tissue material detachment strength of 4 synthetic mesh materials in a rabbit model.
        J Urol. 2005; 174: 2037-2040
        • Roman S.
        • et al.
        Evaluating alternative materials for the treatment of stress urinary incontinence and pelvic organ prolapse: a comparison of the in vivo response to meshes implanted in rabbits.
        J Urol. 2016; 196: 261-269